What Is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was approved in 2021 for patients who are having difficulty losing weight. It has been proven to be extremely effective in weight loss. Most people who took semaglutide lost 15-20% of their total body weight. 

Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced food cravings in addition to improved glycemic control. The greatest weight loss benefits were observed when Semaglutide is used in combination with lifestyle changes, such as improved diet and consistent exercise. 

What to expect from treatment  

Semaglutide is administered as a subcutaneous injection once weekly in office, and may be increased at four-week intervals depending on your tolerance.